GlassScriptPhysician profile
Bethany A Peterson
NPI 1982863106
$6,853.12
in general payments reported to CMS, 2019-2025
53 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,102 · 2020: $139 · 2021: $3,119 · 2022: $510 · 2023: $973 · 2024: $650 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,870 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,869.66 |
| Education | $113.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $2,418.25 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Abbvie INC. | $711.02 | 2019-2025 | |
| Exeltis, USA INC. | $679.60 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $279.14 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $264.79 | 2019-2023 | |
| Pfizer INC. | $243.76 | 2019-2025 | |
| Astellas Pharma US INC | $160.88 | 2023-2024 | Veozah, Myrbetriq |
| Regeneron Healthcare Solutions, INC. | $157.84 | 2019-2023 | Dupixent |
| Sage Therapeutics, LLC | $140.88 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $139.00 | 2022-2025 | Accrufer |
| Coopersurgical, INC. | $124.59 | 2021-2023 | Paragard T 380a |
| Amgen INC. | $121.52 | 2024 | Repatha |
| Inspire Medical Systems, INC. | $98.31 | 2023 | Inspire |
| Amarin Pharma, INC. | $87.00 | 2020-2023 | |
| Organon LLC | $77.20 | 2022-2024 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.